The MSCs is a potential therapeutic for the treatment of LA related testicular dysfunction through the reduction of oxidative stress, reduction of the genotoxic effect, reduction of the apoptosis marker caspase-3, increase the proliferation marker Ki-67 in the testicular tissue and restoration of hormonal imbalance. The gene discussed is CASP3; the disease is testicular disorder.